14 completed, 6 unknown, 2 terminated, 1 active not recruiting. 24 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 24 | Completed 14, Unknown 6, Terminated 2, Active not recruiting 1, Recruiting 1 |
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
Follow Premature Ejaculation: new trials by email Literature Review of Premature Ejaculation trials Research Report on Premature Ejaculation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation 25 units botox, 50 units Botox, 75 units Botox - Premature Ejaculation | Phase 2 / Phase 3 | Active not recruiting | Abdallah Mohamed Abdallah Mohamed Elgendy | 45 | 2024-07-01 | 2025-02-28 |
| Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation Toronto association, Tadalafil, Tadalafil placebo - Erectile Dysfunction, Premature Ejaculation | Phase 3 | Unknown | EMS | 232 | 2024-07-01 | 2023-04-12 |
| On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation sildosin 4mg, dapoxetine 60mg - Premature (Early) Ejaculation | Phase 2 / Phase 3 | Completed | Benha University | 95 | 2024-03-01 | 2025-07-23 |
| Effectiveness and Safety of TENS Therapy for Premature Ejaculation Tens therapy, Dapoxetine placebo, Standard treatment (dapoxetine 30 mg as needed) - Premature Ejaculation, Sex Disorder | Phase 3 | Recruiting | Boston Medical Group | 129 | 2022-06-15 | 2024-05-22 |
| Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction Dapoxetine, Tadalafil - Premature Ejaculation, Erectile Dysfunction | Phase 3 | Unknown | Yan-Ping Huang | 150 | 2020-06-03 | 2020-04-24 |
| Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone. Tadalafil and Combined Dapoxietine, Dapoxietine and Combined Lidocaine 5% Spray - Premature Ejaculation | Phase 3 | Unknown | Sohag University | 60 | 2020-03-30 | 2021-01-11 |
| Effect of Tamsulosin on PE Compared With Paroxetine Hydrochloride Tamsulosin, Paroxetine Hydrochloride, placebo - Premature Ejaculation | Phase 3 | Unknown | Assiut University | 160 | 2019-04-01 | 2019-03-19 |
| Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation Multi-Vitamin Tablets, Dapoxetine, Dapoxetine and folic acid. - Premature Ejaculation | Phase 3 | Completed | Sohag University | 120 | 2019-02-10 | 2019-09-11 |
| Effects of Proxelan Somministration in Patients With Chronic Prostatitis Proxelan - Chronic Prostatitis, Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Phase 3 | Unknown | University of Pisa | 30 | 2017-02-16 | 2018-08-14 |
| Glans Penis Augmentation by Hyaluronic Acid for Treatment of Premature Ejaculation Hyaluronic Acid - Premature Ejaculation | Phase 3 | Completed | Cairo University | 30 | 2016-08-19 | 2018-03-13 |
| Efficacy of Promescent Lidocaine Spray in Men With Premature Ejaculation Placebo, Promescent Lidocaine Spray - Premature Ejaculation | Phase 3 | Unknown | Eugene Y Rhee, MD | 120 | 2014-03-01 | 2014-09-16 |
| Trial of PED-1 in Male Patients With Premature Ejaculation Clomipramine - Premature Ejaculation | Phase 3 | Completed | Symyoo | 159 | 2011-09-01 | 2012-10-03 |
| The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy Dapoxetine - Sexual Dysfunction, Physiological | Phase 3 | Completed | Janssen Research & Development, LLC | 285 | 2010-05-22 | 2024-11-19 |
| Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction Placebo, Dapoxetine, PDE5I (phosphodiesterase-5 inhibitor) - Erectile Dysfunction, Sexual Dysfunction | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 495 | 2010-04-01 | 2013-01-24 |
| Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation Tramadol Hydrochloride, Placebo - Premature Ejaculation | Phase 3 | Terminated | Bausch Health Americas, Inc. | 1050 | 2009-10-01 | 2012-08-27 |
| Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation Tramadol Hydrochloride & Placebo - Premature Ejaculation | Phase 3 | Terminated | Bausch Health Americas, Inc. | 1050 | 2009-08-01 | 2012-08-27 |
| Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation paroxetine, placebo - Premature Ejaculation | Phase 3 | Completed | MorePharma Corporation | 174 | 2008-08-01 | 2009-12-02 |
| Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation PSD502, contains a mixture of lidocaine and prilocaine, Placebo - Premature Ejaculation | Phase 2 / Phase 3 | Completed | Plethora Solutions Ltd | 256 | 2007-10-01 | 2016-09-26 |
| A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation Dapoxetine - Erectile Dysfunction | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1067 | 2005-03-01 | 2011-06-08 |
| A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation dapoxetine - Erectile Dysfunction | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1116 | 2004-12-01 | 2011-06-08 |
Showing 20 of 24. Sign in to see all of them.
Sexual Dysfunction, Physiological (9) · Coitus (6) · Erectile Dysfunction (6) · Sexual Dysfunctions, Psychological (6) · Premature Birth (1) · Prostatitis (1)
Ejaculatory Dysfunction (24) · Genital Diseases (24) · Genital Diseases, Male (24) · Male Urogenital Diseases (24) · Mental Disorders (24) · Urogenital Diseases (24) · Sexual Dysfunctions, Psychological (18) · Sexual Dysfunction, Physiological (15) · Behavior (6) · Sexual Behavior (6) · Female Urogenital Diseases and Pregnancy Complications (1) · Obstetric Labor Complications (1) · Obstetric Labor, Premature (1) · Pregnancy Complications (1) · Prostatic Diseases (1)
dapoxetine (12) · Tadalafil (3) · Paroxetine (2) · Tramadol (2) · Clomipramine (1) · Folic Acid (1) · Geritol (1) · Health Services Needs and Demand (1) · Hyaluronic Acid (1) · Lidocaine (1) · Lidocaine, Prilocaine Drug Combination (1) · Phosphodiesterase 5 Inhibitors (1) · Prilocaine (1) · Proxelan (1) · Tamsulosin (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (4) · Alza Corporation, DE, USA (3) · Bausch Health Americas, Inc. (2) · Sohag University (2) · Abdallah Mohamed Abdallah Mohamed Elgendy (1) · Assiut University (1) · Benha University (1) · Boston Medical Group (1) · Cairo University (1) · EMS (1) · Eugene Y Rhee, MD (1) · Janssen Research & Development, LLC (1) · MorePharma Corporation (1) · Plethora Solutions Ltd (1) · Symyoo (1)
Egypt (4) · Mexico (3) · South Korea (3) · United States (3) · Australia (2) · Belgium (2) · France (2) · Poland (2) · Argentina (1) · Austria (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Germany (1) · Hungary (1)
Abdelraouf Elmohsen, Professor (1) · Ahmed Elshahid, Professor (1) · Culley Carson, MD (1) · Eugene Y Rhee, MD, MBA (1) · Eusebio Rubio-Aurioles, M.D, Ph.D. (1) · Hamed A Hamed, MD (1) · Hubert Claes, MD (1) · Jorge Barba, MD (1) · Mohammed A El-Hamd (1) · Mohammed Abu El-Hamd, MD (1) · Peter Nyiradi, MD (1) · Whan-Seok Choi, MD,PhD (1)
PMID 21059176, PMID 16962882, PMID 20412423, PMID 21889833, PMID 19195772, PMID 19878447, PMID 20367770, PMID 23845016
2009 (1)